These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 35451354)

  • 1. Preliminary attitudes on medications for opioid use disorders (MOUDs) in Southeastern Switzerland and New York City.
    Castillo F; Scalise D; Hernandez D; Gupta R; Basaraba CN; Corbeil T; Comer SD; Schneeberger AR
    J Addict Dis; 2023; 41(1):91-97. PubMed ID: 35451354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One size does not fit all-evolution of opioid agonist treatments in a naturalistic setting over 23 years.
    Nordt C; Vogel M; Dey M; Moldovanyi A; Beck T; Berthel T; Walter M; Seifritz E; Dürsteler KM; Herdener M
    Addiction; 2019 Jan; 114(1):103-111. PubMed ID: 30209840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attitudes Regarding Medications for Opioid Use Disorder Among Peer Recovery Coaches.
    Suzuki J; Loguidice F; Martin B
    J Addict Med; 2023 Jan-Feb 01; 17(1):101-103. PubMed ID: 35914085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-prescribing clinicians' treatment orientations and attitudes toward treatments for opioid use disorder: Rural differences.
    Brown AR; Walters JE; Harmer B; Cates L; Jones AE
    J Subst Use Addict Treat; 2023 Dec; 155():209153. PubMed ID: 37673286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beliefs about medications for opioid use disorder among Florida criminal problem-solving court & dependency court staff.
    Andraka-Christou B; Atkins D
    Am J Drug Alcohol Abuse; 2020 Nov; 46(6):749-760. PubMed ID: 32969757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attitudes and beliefs among Georgia addiction treatment staff about medication for opioid use disorder in adolescents, young adults, and adults: a multi-mixed methods study.
    Welsh JW; Mataczynski MJ; Passetti LL; Hunter BD; Godley MD
    Am J Drug Alcohol Abuse; 2022 May; 48(3):347-355. PubMed ID: 35416739
    [No Abstract]   [Full Text] [Related]  

  • 7. Perspectives Regarding Medications for Opioid Use Disorder Among Individuals with Mental Illness.
    Tarn DM; Shih KJ; Ober AJ; Hunter SB; Watkins KE; Martinez J; Montero A; McCreary M; Leamon I; Sheehe J; Bromley E
    Community Ment Health J; 2023 Feb; 59(2):345-356. PubMed ID: 35906435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. College students' perceived knowledge of and perceived helpfulness of treatments for opioid use disorder at two American universities.
    Andraka-Christou B; Nguyen T; Harris S; Madeira J; Totaram R; Randall-Kosich O; Atkins D; Ford J
    Am J Drug Alcohol Abuse; 2020 Sep; 46(5):589-603. PubMed ID: 32543922
    [No Abstract]   [Full Text] [Related]  

  • 9. Who receives heroin-assisted treatment? A comparison of patients receiving opioid maintenance treatment in Denmark.
    Melis F; Hesse M; Eide D; Thylstrup B; Tjagvad C; Brummer JE; Clausen T
    Drug Alcohol Depend; 2024 Jan; 254():111051. PubMed ID: 38091901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health professionals' attitudes toward medications for opioid use disorder.
    Brown AR
    Subst Abus; 2022; 43(1):598-614. PubMed ID: 34520703
    [No Abstract]   [Full Text] [Related]  

  • 11. Opioid use disorder incidence and treatment among incarcerated pregnant women in the United States: results from a national surveillance study.
    Sufrin C; Sutherland L; Beal L; Terplan M; Latkin C; Clarke JG
    Addiction; 2020 Nov; 115(11):2057-2065. PubMed ID: 32141128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Buprenorphine prescribing for opioid use disorder in medical practices: can office-based out-patient care address the opiate crisis in the United States?
    Rhee TG; Rosenheck RA
    Addiction; 2019 Nov; 114(11):1992-1999. PubMed ID: 31307111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Buprenorphine prescribing practice trends and attitudes among New York providers.
    Kermack A; Flannery M; Tofighi B; McNeely J; Lee JD
    J Subst Abuse Treat; 2017 Mar; 74():1-6. PubMed ID: 28132694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Awareness of, experience with, and attitudes toward buprenorphine among opioid users visiting a New York City syringe exchange program.
    Shah PA; Sohler NL; López C; Fox AD; Cunningham CO
    J Opioid Manag; 2013; 9(6):407-13. PubMed ID: 24481929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medications for Opioid Use Disorder During Incarceration.
    McDermott-Winger ER; Latham CL
    J Addict Nurs; 2022 Jul-Sep 01; 33(3):182-190. PubMed ID: 36041161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Criminal problem-solving and civil dependency court policies regarding medications for opioid use disorder.
    Andraka-Christou B; Clark MH; Atkins DN; Del Pozo B
    Subst Abus; 2022; 43(1):425-432. PubMed ID: 34236297
    [No Abstract]   [Full Text] [Related]  

  • 17. Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.
    Jones CM; Shoff C; Hodges K; Blanco C; Losby JL; Ling SM; Compton WM
    JAMA Psychiatry; 2022 Oct; 79(10):981-992. PubMed ID: 36044198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a claim-based provider-level measurement of use of medications to treat opioid use disorder.
    Dowd WN; Barch DH; Seibert JH; Mark TL
    J Subst Abuse Treat; 2022 Sep; 140():108824. PubMed ID: 35780730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consumer attitudes about opioid addiction treatment: a focus group study in New York City.
    Sohler NL; Weiss L; Egan JE; López CM; Favaro J; Cordero R; Cunningham CO
    J Opioid Manag; 2013; 9(2):111-9. PubMed ID: 23709320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient Barriers and Facilitators to Medications for Opioid Use Disorder in Primary Care.
    Tofighi B; Williams AR; Chemi C; Suhail-Sindhu S; Dickson V; Lee JD
    Subst Use Misuse; 2019; 54(14):2409-2419. PubMed ID: 31429351
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.